Immunohistochemistry (IHC) Market Soaring at 7.3% CAGR to 2021 Led by Antibody Segment

Friday, December 2, 2016 Drug News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, December 2, 2016 /PRNewswire/ --

The immunohistochemistry (IHC) market is projected to reach

USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period of 2016 to 2021 dominated by immunohistochemistry (IHC) antibody segment while hospitals and diagnostic laboratories segment accounted for the largest share of immunohistochemistry
(IHC) market, by end user.

Complete report on global immunohistochemistry (IHC) market spread across 225 pages, profiling 10 companies and supported with 181 tables and 44 figures is now available at .

Factors such as the growing prevalence of cancer and rapidly increasing geriatric population across the globe are the primary driving the growth of this market. Other factors driving the IHC market growth include increasing healthcare spending and improving healthcare infrastructure resulting in an increasing number of hospitals and diagnostic laboratories. Several manufacturers in the immunohistochemistry (IHC) market are relied majorly on launching the new products in order to achieve growth in the immunohistochemistry (IHC) market. In addition, market players are focusing on acquiring local market players to expand their portfolios and enhance their distribution channels in emerging markets.

The global immunohistochemistry (IHC) market is segmented based on product, application, end user, and region. Based on product, the immunohistochemistry (IHC) market is segmented into antibodies, reagents, equipment, and kits. Based on application, the immunohistochemistry (IHC) market is segmented into diagnostics and drug testing. The diagnostic segment is further divided into cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetes, and nephrological diseases. On the basis of end user, the market is segmented into hospitals & diagnostic laboratories, research institutions, and other end users. This report also provides market information across major regional segments, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America is the largest market for immunohistochemistry (IHC), followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific possesses lucrative growth potential for the immunohistochemistry (IHC) market during the forecast period. The economic growth of APAC countries, rising number of chronic diseases, rising standard of living, growing demand for quality medical care, increasing healthcare spending and government initiatives, and rising awareness on the use of immunohistochemistry (IHC) tests are expected to drive market growth of the Asia-Pacific region during the forecast period.

The global immunohistochemistry (IHC) market is consolidated at the top with the top five companies accounting for more than half of the global market. The major players in the immunohistochemistry market include F. Hoffman-La Roche AG (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abcam plc (U.K.), Cell Signaling Technology, Inc. (U.S.), and Bio SB Inc. (U.S.). Order a copy of Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021 research report at .

This report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater market share. Firms purchasing this report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

On a related note, another research on Cell Isolation/Cell Separation Market Global Forecast to 2021 says, the global cell isolation market is expected to reach USD 7.89 billion by 2021 from USD 3.57 billion in 2016, at a CAGR of 17.2%. The centrifugation-based cell isolation segment is expected to account for the largest share of the global market. On the basis of cell type, the human cells segment is expected to account for the largest share of the globally. Companies like Beckman Coulter (U.S.), Thermo Fisher Scientific Inc. (U.S.), Becton Dickinson and Company (U.S.), and Bio-Rad Laboratories Inc. (U.S.) have been profiled in this 172 pages research report available at .

Explore more reports on the biotechnology market at

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact: Ritesh Tiwari 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India. Tel:  +1-888-391-5441

Connect with Us:  



Twitter: https: //

G+ / Google Plus:


RSS/Feeds:  http: //

SOURCE ReportsnReports


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store